tiprankstipranks
Voyageur Pharmaceuticals (TSE:VM)
:VM
Canadian Market
VM
Voyageur Pharmaceuticals
RESEARCH TOOLSreports

Voyageur Pharmaceuticals (VM) Financial Statements

Compare
20 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently C$21.43M. The company's EPS TTM is C$; its P/E ratio is -5.29; Voyageur Pharmaceuticals is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 25Feb 24Feb 23Feb 22Nov 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25KC$ -1.48K
Operating IncomeC$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05MC$ -848.94K
EBITDAC$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05MC$ -1.12M
Net IncomeC$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14M
Balance Sheet
Cash & Short-Term InvestmentsC$ 165.57KC$ 2.08KC$ 31.56KC$ 812.97KC$ 2.97K
Total AssetsC$ 2.60MC$ 2.16MC$ 2.10MC$ 2.57MC$ 1.28M
Total DebtC$ 40.00KC$ 40.00KC$ 25.52KC$ 42.08KC$ 268.41K
Net DebtC$ -125.57KC$ 37.91KC$ -6.04KC$ -770.89KC$ 265.44K
Total LiabilitiesC$ 2.15MC$ 727.88KC$ 630.83KC$ 660.64KC$ 968.85K
Stockholders' EquityC$ 449.96KC$ 1.44MC$ 1.46MC$ 1.91MC$ 306.33K
Cash Flow
Free Cash FlowC$ -302.29KC$ -991.25KC$ -2.00MC$ -2.09MC$ -434.13K
Operating Cash FlowC$ -302.29KC$ -991.25KC$ -1.72MC$ -1.65MC$ -272.19K
Investing Cash FlowC$ -165.96KC$ -174.72KC$ -274.15KC$ -432.08KC$ -151.79K
Financing Cash FlowC$ 631.73KC$ 1.14MC$ 1.21MC$ 2.90MC$ 351.34K
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Income Statement >

Voyageur Pharmaceuticals Debt to Assets

Balance Sheet >

Voyageur Pharmaceuticals Cash Flow

Cash Flow >

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >